Humoral and cellular immunity against diverse SARS-CoV-2 variants  

作　　者：Changxu Chen Xin Wang Zeli Zhang 

机构地区：[1]Center for Infectious Disease Research,School of Life Science,Westlake University,Hangzhou,Zhejiang 310001,China

出　　处：《Journal of Genetics and Genomics》2023年第12期934-947,共14页遗传学报（英文版）

摘　　要：Since the outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in late 2019, the virus has rapidly spread worldwide. This has led to an unprecedented global pandemic, marked by millions of COVID-19 cases and a significant number of fatalities. Over a relatively short period, several different vaccine platforms are developed and deployed for use globally to curb the pandemic. However, the genome of SARS-CoV-2 continuously undergoes mutation and/or recombination, resulting in the emergence of several variants of concern (VOC). These VOCs can elevate viral transmission and evade the neutralizing antibodies induced by vaccines, leading to reinfections. Understanding the impact of the SARS-CoV-2 genomic mutation on viral pathogenesis and immune escape is crucial for assessing the threat of new variants to public health. This review focuses on the emergence and pathogenesis of VOC, with particular emphasis on their evasion of neutralizing antibodies. Furthermore, the memory B cell, CD4+, and CD8+ T cell memory induced by different COVID-19 vaccines or infections are discussed, along with how these cells recognize VOC. This review summarizes the current knowledge on adaptive immunology regarding SARS-CoV-2 infection and vaccines. Such knowledge may also be applied to vaccine design for other pathogens.

关 键 词：SARS-CoV-2 COVID-19 Vaccines Humoral immunity Cellular immunity 

分 类 号：R373[医药卫生—病原生物学]